NovaGray

NOVAGRAY

In the statement, at the end of line 25 , all of the foregoing services limited to the field of analyzing biological samples for predicting the risk of a patient developing physical complications due to radiotherapy treatment is inserted.;Pharmaceutical products for preventing side effects of radiotherapy cancer treatments; veterinary pharmaceutical products for preventing side effects of radiotherapy cancer treatments; chemical preparations for pharmaceutical or medical purposes, namely, for preventing side effects of radiotherapy cancer treatments; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical and veterinary use; diagnostic test equipment in the nature of medical diagnostic test strips for blood analysis for medical or veterinary use; chemical preparations for testing blood for medical purposes;Medical services; medical diagnostic testing, monitoring and reporting services; medical analysis services for preventing side effects of radiotherapy cancer treatments; medical testing of urine, blood, hair follicles and breath; web-based oncological analysis services for medical diagnostic and treatment purposes; medical counseling services; medical assistance; hospital services *, none of the foregoing services offered in connection with radiation dose monitoring software *;Design, development, maintenance and updating of computer software; design, development, updating and maintenance of computer software for carrying out algorithms; computer programming in the medical field; computer programming services for medical applications; design and development of computer software for use in the field of medical technology; development of information system software and artificial intelligence computer system software for medical purposes; design, engineering, research, development and testing of computer software for medical applications; scientific research; design of computer software for database management; design, development, updating and maintenance of software and database systems; software as a service (SaaS) services, namely, hosting software for use by others for use in analyzing health data; medical research; biological research; research and development in the pharmaceutical and biotechnology field; medical laboratory services; software as a service (SAAS) services featuring computer software applications for analyzing health data; platform as a service (PAAS) featuring computer software platforms for analyzing health data *, all of the foregoing services limited to the field of analyzing biological samples for predicting the risk of a patient developing physical complications due to radiotheraphy treatment *;